Loading...
•
Mar 28, 2020
Henry Schein Q1 2020 Earnings Report
Henry Schein's Q1 2020 financial results were reported, showing an increase in net sales and EPS compared to the previous year, but were significantly impacted by the COVID-19 pandemic in March.
Key Takeaways
Henry Schein reported a 2.9% increase in net sales to $2.4 billion for Q1 2020. GAAP diluted EPS from continuing operations was $0.91, and non-GAAP diluted EPS was $0.94. The company's results were significantly impacted by the COVID-19 pandemic, particularly in the Dental business.
Q1 GAAP diluted EPS from continuing operations was $0.91, up from $0.78 in the prior year.
Q1 non-GAAP diluted EPS from continuing operations was $0.94, compared to $0.80 in the prior year.
Net sales increased by 2.9% to $2.4 billion, driven by 4.0% growth in local currencies.
The COVID-19 pandemic significantly impacted the Dental business, while Medical and Technology and Value-Added Services businesses were more resilient.
Henry Schein
Henry Schein
Henry Schein Revenue by Segment
Henry Schein Revenue by Geographic Location
Revenue by Segment
Global Dental Revenue
CapyFin.comGlobal Medical Revenue
CapyFin.comRevenue by Geographic Location
U.S. Distribution and Value-Added Services Revenue
CapyFin.comInternational Distribution and Value-Added Services Revenue
CapyFin.com Forward Guidance
Henry Schein withdrew its previously announced financial guidance for 2020 due to the continued uncertainty surrounding COVID-19 and its impact on business operations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income